Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
EN
/
CN
Home
About Leecan
Overview of Leecan
History
Corporate Culture
Honor
Responsibility
Product
Marketed Products
Regulatory Review
In Development
Production and Research Platform
Research and Development Platform
Production and Operation
Quality Assurance
CMO/CDMO
News regulations
Investor
Careers
Talent Concept
People in leecan
Recruitment
Career development
Contact Us
Cooperation
Supplier Cooperation
Recruitment
Pharmacovigilance
CMO/CDMO
Issue 10: Focusing on the Latest Core Regulations for Drug Review and Pricing
Release time：2026-07-08
share:
Previous article：Issue 11: Key Updates in Medical and Pharmaceutical Regulations for Early to Mid-2026
next article：Issue 9: NMPA/CDE Guidelines and Industry Trends
Back to list
You may also want to read
Issue 5: Focusing on the revised GCP and other new pharmaceutical regulations
2026.07.06
Production approvals were obtained for budesonide suspension for inhalation and salbutamol sulphate solution for inhalation!
2024.06.25
Issue 3: Innovative Drugs and AI Empowerment: A Quick Look at New Pharma Regulations
2026.07.06
